Takeda Pharmaceutical Co., LTD et al v. Handa Pharmaceuticals, LLC

Filing 45

STIPULATION AND ORDER TO CONTINUE CASE MANAGEMENT CONFERENCE. Joint Case Management Statement due by 8/5/2011. Case Management Conference set for 8/12/2011 at 01:30 PM in Courtroom G, 15th Floor, San Francisco. Signed by Judge Joseph C. Spero on 6/29/11. (klhS, COURT STAFF) (Filed on 6/30/2011)

Case3:11-cv-00840-JCS Document44

1
2
3
4
5
6
7
8
9
10

Filed06/28/11 Page1 of 5

JEFFREY I. WEINBERGER (SBN 056214)
[e-mail]
TED G. DANE (SBN 143195)
[e-mail]
HEATHER E. TAKAHASHI (SBN 245845)
[e-mail]
MUNGER, TOLLES & OLSON LLP
355 South Grand Avenue, 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]
Attorneys for Plaintiffs
TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.

11

UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION

12
13
14
15
16

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

v.

18

Judge:

22
23

Defendant.
TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

v.

25

27

Case No. 3:11-cv-01609 JCS

Plaintiffs,

24

26

Hon. Joseph C. Spero

HANDA PHARMACEUTICALS, LLC,

20
21

STIPULATION TO CONTINUANCE OF CASE
MANAGEMENT CONFERENCE;
[PROPOSED] ORDER THEREON

Plaintiffs,

17

19

Case No. 3:11-cv-00840 JCS

ANCHEN PHARMACEUTICALS, INC., AND
TWI PHARMACEUTICALS, INC.,
Defendants.

28
STIPULATION TO CONTINUANCE OF CASE
MANAGEMENT CONFERENCE;
[PROPOSED] ORDER THEREON

Case3:11-cv-00840-JCS Document44

1
2
3

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

4

Filed06/28/11 Page2 of 5

Case No. 3:11-cv-01610 JCS

Plaintiffs,

5

v.

6

IMPAX LABORATORIES, INC.,

7

Defendant.

8
9

Plaintiffs Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North

10

America, Inc., Takeda Pharmaceuticals LLC, and Takeda Pharmaceuticals America, Inc.

11

(collectively, “Takeda”), and Defendants Handa Pharmaceuticals, LLC (“Handa”), Anchen

12

Pharmaceuticals, Inc. (“Anchen”), TWi Pharmaceuticals, Inc. (“TWi”), and Impax Laboratories,

13

Inc. (“Impax”) (collectively, “Defendants”), hereby stipulate through their respective attorneys as

14

follows:

15

WHEREAS, on June 23, 2011, the Court issued an Order Setting Case Management

16

Conference in the above-captioned actions, scheduling a Case Management Conference for July

17

29, 2011, at 1:30 p.m.;

18
19

WHEREAS, Takeda would request a continuance of the Case Management Conference to
better accommodate its counsels’ schedules;

20
21

WHEREAS, the parties agree that Friday, August 12, 2011, at 1:30 p.m. is a mutually
agreeable date for a rescheduled Case Management Conference.

22

NOW THEREFORE, IT IS HEREBY STIPULATED that, subject to the Court’s approval,

23

the Case Management Conference shall be held on Friday, August 12, 2011, at 1:30 p.m. and the

24

other dates in the Order Setting Case Management Conference are continued accordingly.

25

//

26

//

27

//

28
2

STIPULATION TO CONTINUANCE OF CASE
MANAGEMENT CONFERENCE;
[PROPOSED] ORDER THEREON

Case3:11-cv-00840-JCS Document44

1

Filed06/28/11 Page3 of 5

Respectfully Submitted,

2
3
4
5

DATED: June 28, 2011

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.

6
7
8
9
10
11
12
13

By:
/s/ Heather E. Takahashi
Jeffrey I. Weinberger (SBN 056214)
[e-mail]
Ted G. Dane (SBN 143195)
[e-mail]
Heather E. Takahashi (SBN 245845)
[e-mail]
MUNGER, TOLLES & OLSON LLP
355 South Grand Ave., 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]

14
15

HANDA PHARMACEUTICALS, LLC

16
17
18
19
20
21
22
23
24
25
26
27

By:
/s/ Steven A. Maddox
William R. Zimmerman (SBN 195859)
[e-mail]
Steven A. Maddox (pro hac vice)
[e-mail]
KNOBBE, MARTENS, OLSON & BEAR, LLP
1717 Pennsylvania Ave., Ste. 900
Washington, D.C. 20006
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]
Payson J. LeMeilleur (SBN 205690)
[e-mail]
KNOBBE, MARTENS, OLSON & BEAR, LLP
2040 Main Street, 14th Floor
Irvine, CA 92614
Telephone: [phone]
Facsimile: [phone]

28
3

STIPULATION TO CONTINUANCE OF CASE
MANAGEMENT CONFERENCE;
[PROPOSED] ORDER THEREON

Case3:11-cv-00840-JCS Document44

Filed06/28/11 Page4 of 5

ANCHEN PHARMACEUTICALS, INC. AND
TWI PHARMACEUTICALS, INC.

1
2
3

By:
/s/ Don J. Mizerk
Don J. Mizerk (SBN 208477)
[e-mail]
HUSCH BLACKWELL LLP
120 S. Riverside Plaza, Suite 2200
Chicago, IL 60606
Telephone: [phone]
Facsimile: [phone]

4
5
6
7
8

IMPAX LABORATORIES, INC.

9
10

By:
/s/ Brian F. McMahon
Brian F. McMahon (SBN 235373)
[e-mail]
MORRISON & FOERSTER LLP
555 W 5th St 35th Fl
Los Angeles, CA 90013
Telephone: [phone]
Facsimile: [phone]

11
12
13
14
15
16

Attorneys for Defendant
IMPAX LABORATORIES, INC.

17
18
19

Filer’s Attestation

I, Heather Takahashi, am the ECF user whose identification and password are

20

being used to file this STIPULATION TO CONTINUANCE OF CASE

21

MANAGEMENT CONFERENCE. In compliance with General Order 45.X.B, I

22

hereby attest that the other above-named signatory concurs in this filing.

23

DATED: June 28, 2011

24
25

/s/ Heather E. Takahashi

26
27
28
4

STIPULATION TO CONTINUANCE OF CASE
MANAGEMENT CONFERENCE;
[PROPOSED] ORDER THEREON

Filed06/28/11 Page5 of 5

2

June 29
DATED: ___________, 2011

S DISTRICT
TE
C
TA

UNIT
ED

S

PURSUANT TO STIPULATION, IT IS SO ORDERED.

RT
U
O

1

3
4

R NIA

Case3:11-cv-00840-JCS Document44

NO

THE HONORABLE JOSEPH C. SPERO
UNITED STATES MAGISTRATE JUDGE
o
C. Sper

7

A

H

ER

FO

RT

6

seph

Judge Jo

LI

5

N

F
D IS T IC T O
R

C

8
9
10
11

14328274.1

12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
5

STIPULATION TO CONTINUANCE OF CASE
MANAGEMENT CONFERENCE;
[PROPOSED] ORDER THEREON